EyePoint, Inc.·4

Feb 18, 4:07 PM ET

Ribeiro Ramiro 4

Research Summary

AI-generated summary

Updated

EyePoint (EYPT) CMO Ribeiro Ramiro Exercises Options, Sells Shares

What Happened
Ribeiro Ramiro, Chief Medical Officer of EyePoint, exercised 2,437 stock options on Feb 17, 2026 at a $8.26 strike ($20,130 total) and sold the 2,437 resulting shares the same day at $15.00 per share, generating $36,555. The filing shows the derivative (the option) was converted/terminated as part of the exercise.

Key Details

  • Transaction date: 2026-02-17; Form 4 filed 2026-02-18 (timely). Accession: 0002013623-26-000006.
  • Exercise: 2,437 shares acquired via option exercise (code M) at $8.26 per share = $20,130.
  • Sale: 2,437 shares sold (code S) at $15.00 per share = $36,555.
  • Derivative entry: 2,437 shares reported as disposed at $0 — reflects conversion/termination of the option instrument after exercise.
  • Shares owned after transaction: Not disclosed in the provided filing.
  • Footnote: The option vests 25% on Jan 3, 2026, then ratably monthly over the next three years (see F1).
  • No 10b5-1 plan, tax-withholding, or late filing noted in the filing text provided.

Context
Because the exercised shares were sold the same day, this is effectively a cashless exercise (exercise followed by immediate sale). For retail investors: the sequence is common when insiders exercise vested options and sell shares to cover the exercise cost and taxes; it documents the mechanics (option exercise + sale) but does not, by itself, reveal the insider’s view of the company’s prospects. Transaction codes: M = option exercise, S = sale.